Varicose Vein Treatment Market Overview:The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025. Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.
Get Free Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-AMR-HnM-440205
Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.
The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key Benefits for varicose vein treatment market:The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities. A comprehensive analysis of all the regions is provided to determine the existing opportunities.The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-AMR-HnM-440205
Varicose Vein Treatment Key Market Segments:
By ProcedureInjection SclerotherapyEndovenous AblationSurgical Ligation/Stripping
By ProductSclerotherapy injectionAblation DevicesRadiofrequency Ablation DevicesLaser Ablation DevicesOthersOthers
By End User HospitalsClinicsAmbulatory centers
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Alma Lasers LtdAngiodynamics, IncBiolitec AGBTG PLCEnergist LtdMedtronicLumenisSciton IncSyneronWONTECH Co., Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
TeleflexThe Vein CompanyF care SystemsMiravasSharpLight Technologies
Purchase Complete Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-AMR-HnM-440205/
By Region
North AmericaU.S.CanadaMexicoEuropeGermanyFranceUKItalySpainRest of EuropeAsia-PacificJapanChina AustraliaIndiaSouth KoreaRest of Asia-PacificLAMEABrazilSaudi ArabiaSouth AfricaRest of LAMEA
Media ContactCompany Name: Qurate Business IntelligenceContact Person: Nehal ChinoyEmail: Send EmailPhone: +919881074592Address:Runwal Platinum, Ramnagar Colony, Bavdhan City: PuneState: MaharashtraCountry: IndiaWebsite: www.qurateresearch.com